SCHEMBL27907705

SCHEMBL27907705

COc1ccc(Nc2ncc3cc(-c4cccc(C#N)c4)ccc3n2)cc1Cl

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP4K1 Q92918 1/20 0.49
ABCG2 Q9UNQ0 3/20 0.46
EPHB4 P54760 1/20 0.45
IGF1R P08069 1/20 0.45
MAPT P10636 3/20 0.45
GAA P10253 1/20 0.45
SYK P43405 1/20 0.45
PTK2 Q05397 1/20 0.44
BRAF P15056 2/20 0.44
ALDH1A1 P00352 1/20 0.44
STK17B O94768 1/20 0.44
STK17A Q9UEE5 1/20 0.44
NPC1 O15118 1/20 0.44
RAB9A P51151 1/20 0.44
PAK1 Q13153 2/20 0.44
MEN1 O00255 1/20 0.43
LMNA P02545 1/20 0.43
KMT2A Q03164 1/20 0.43
MAP3K5 Q99683 1/20 0.43
LRRK2 Q5S007 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12274916 0.81 MEN1 (0.53) EPHB4IGF1RMAPTGAASYK
SCHEMBL27987181 0.81 BRAF (0.50) MAPTGAASYKPTK2BRAF
SCHEMBL12275237 0.79 PAK1 (0.58) PTK2PAK1LRRK2FLT3
SCHEMBL27907697 0.79 EGFR (0.62) ABCG2BRAFALDH1A1MEN1LMNA
SCHEMBL1197401 0.78 SYK (0.72) ABCG2SYK
SCHEMBL12274826 0.74 FLT3 (0.52) ABCG2SYKPTK2BRAFPAK1
SCHEMBL12274361 0.72 MEN1 (0.56) ABCG2SYKBRAFNPC1RAB9A
SCHEMBL2205050 0.70 KDM4E (0.52) ABCG2EPHB4IGF1RMAPTGAA
SCHEMBL1667296 0.69 ABCG2 (0.60) ABCG2MAPTALDH1A1MEN1LMNA
SCHEMBL12273795 0.69 SYK (0.54) SYKBRAFNPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102924387-A 4-(3-chloro-4-methoxyanilino)-6-(3,4-substituted phenyl)quinazoline and salts thereof, preparation method and applications HUANG WEIYAN 2013-02-13 CN disclosed